Literature DB >> 19388004

TGFbeta regulation of membrane mucin Muc4 via proteosome degradation.

Wieslawa M Lomako1, Joseph Lomako, Pedro Soto, Coralie A Carothers Carraway, Kermit L Carraway.   

Abstract

Muc4 is a heterodimeric membrane mucin implicated in epithelial differentiation and tumor progression. It is expressed from a single gene as a 300 kDa precursor protein which is cleaved in the endoplasmic reticulum to its two subunits. Our previous work has shown that Muc4 is regulated by TGFbeta, which represses the precursor cleavage. Working with Muc4-transfected A375 tumor cells, we now show that Muc4 undergoes proteosomal degradation. Proteosome inhibitors prolong the life of the precursor, shunt the Muc4 into cytoplasmic aggresomes, increase the level of Muc4 associated with the endoplasmic reticulum chaperones calnexin and calreticulin and increase the levels of ubiquitinated Muc4. Most importantly, proteosome inhibitors repress the TGFbeta inhibition of Muc4 expression. These results suggest a model in which TGFbeta inhibits precursor cleavage, shunting the precursor into the proteosomal degradation pathway. Thus, the cells have evolved a mechanism to use the quality control pathway for glycoproteins to control the quantity of the protein produced. 2009 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19388004      PMCID: PMC2745306          DOI: 10.1002/jcb.22177

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  26 in total

Review 1.  Aggresomes, inclusion bodies and protein aggregation.

Authors:  R R Kopito
Journal:  Trends Cell Biol       Date:  2000-12       Impact factor: 20.808

Review 2.  Themes and variations on ubiquitylation.

Authors:  A M Weissman
Journal:  Nat Rev Mol Cell Biol       Date:  2001-03       Impact factor: 94.444

Review 3.  Quality control in the endoplasmic reticulum.

Authors:  Lars Ellgaard; Ari Helenius
Journal:  Nat Rev Mol Cell Biol       Date:  2003-03       Impact factor: 94.444

4.  Sialomucin complex (rat Muc4) is regulated by transforming growth factor beta in mammary gland by a novel post-translational mechanism.

Authors:  S A Price-Schiavi; X Zhu; R Aquinin; K L Carraway
Journal:  J Biol Chem       Date:  2000-06-09       Impact factor: 5.157

5.  Reversible disruption of cell-matrix and cell-cell interactions by overexpression of sialomucin complex.

Authors:  M Komatsu; C A Carraway; N L Fregien; K L Carraway
Journal:  J Biol Chem       Date:  1997-12-26       Impact factor: 5.157

6.  Muc4/sialomucin complex, an intramembrane modulator of ErbB2/HER2/Neu, potentiates primary tumor growth and suppresses apoptosis in a xenotransplanted tumor.

Authors:  M Komatsu; S Jepson; M E Arango; C A Carothers Carraway; K L Carraway
Journal:  Oncogene       Date:  2001-01-25       Impact factor: 9.867

7.  SMAD2 and SMAD7 involvement in the post-translational regulation of Muc4 via the transforming growth factor-beta and interferon-gamma pathways in rat mammary epithelial cells.

Authors:  Pedro Soto; Shari A Price-Schiavi; Kermit L Carraway
Journal:  J Biol Chem       Date:  2003-03-31       Impact factor: 5.157

8.  Multidrug resistance correlates with overexpression of Muc4 but inversely with P-glycoprotein and multidrug resistance related protein in transfected human melanoma cells.

Authors:  Yan Ping Hu; Bushra Haq; Kermit L Carraway; Niramol Savaraj; Theodore J Lampidis
Journal:  Biochem Pharmacol       Date:  2003-05-01       Impact factor: 5.858

Review 9.  Regulated ubiquitination of proteins in GPCR-initiated signaling pathways.

Authors:  Richard J H Wojcikiewicz
Journal:  Trends Pharmacol Sci       Date:  2004-01       Impact factor: 14.819

10.  Rat Muc4 (sialomucin complex) reduces binding of anti-ErbB2 antibodies to tumor cell surfaces, a potential mechanism for herceptin resistance.

Authors:  Shari A Price-Schiavi; Scott Jepson; Peter Li; Maria Arango; Philip S Rudland; Lisa Yee; Kermit L Carraway
Journal:  Int J Cancer       Date:  2002-06-20       Impact factor: 7.396

View more
  6 in total

1.  Effects of thymoquinone in the expression of mucin 4 in pancreatic cancer cells: implications for the development of novel cancer therapies.

Authors:  Maria P Torres; Moorthy P Ponnusamy; Subhankar Chakraborty; Lynette M Smith; Srustidhar Das; Hwyda A Arafat; Surinder K Batra
Journal:  Mol Cancer Ther       Date:  2010-04-27       Impact factor: 6.261

Review 2.  Post-translational regulation of signaling mucins.

Authors:  Paul J Cullen
Journal:  Curr Opin Struct Biol       Date:  2011-08-31       Impact factor: 6.809

Review 3.  Transmembrane Mucins: Signaling Receptors at the Intersection of Inflammation and Cancer.

Authors:  Jos P M van Putten; Karin Strijbis
Journal:  J Innate Immun       Date:  2017-01-05       Impact factor: 7.349

Review 4.  Muc4/MUC4 functions and regulation in cancer.

Authors:  Kermit L Carraway; George Theodoropoulos; Goldi A Kozloski; Coralie A Carothers Carraway
Journal:  Future Oncol       Date:  2009-12       Impact factor: 3.404

5.  Regulation of the membrane mucin Muc4 in corneal epithelial cells by proteosomal degradation and TGF-beta.

Authors:  Joseph Lomako; Wieslawa M Lomako; Coralie A Carothers Carraway; Kermit L Carraway
Journal:  J Cell Physiol       Date:  2010-04       Impact factor: 6.384

Review 6.  The role of membrane mucin MUC4 in breast cancer metastasis.

Authors:  Courtney A Dreyer; Kacey VanderVorst; Savannah Free; Ashley Rowson-Hodel; Kermit L Carraway
Journal:  Endocr Relat Cancer       Date:  2021-11-24       Impact factor: 5.678

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.